Seedless synthesis of anisotropic gold nanoflowers with cellular control and drug delivery applications

US12485484B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12485484-B2
Application numberUS-202318197195-A
CountryUS
Kind codeB2
Filing dateMay 15, 2023
Priority dateMay 17, 2022
Publication dateDec 2, 2025
Grant dateDec 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A new seedless synthesis of anisotropic nanoscale gold nanoflower (AuNF) particles uses bidentate thiolate ligands to protect the nanoparticle surface and a combination of reagents (for example, ligand, ascorbic acid, and hydroxide) to synthesis AuNF with controlled size and anisotropic properties. Compared to prior art gold nanospheres, AuNF produced approximately a 15-fold improvement in a drug delivery assay.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of synthesizing anisotropic gold nanoparticles, the method comprising: providing aurate ions, a ligand comprising thioctic acid, a reducing agent, and hydroxide and allowing them to react in an aqueous phase, thereby obtaining anisotropic gold nanoparticles having diameters in a range of 15-500 nm. 2 . The method of claim 1 , wherein the reducing agent is ascorbic acid. 3 . The method of claim 1 , wherein the ligand is selected from the group consisting of thioctic acid-NH 2 (TA-NH 2 ), TA-nitrilotriacetic acid (TA-NTA), TA-polyethylene glycol-COOH (TA-PEG-COOH), and TA-polyethylene glycol-NH 2 (TA-PEG-NH 2 ). 4 . The method of claim 1 , wherein, by controlling reaction conditions, one can obtain nanoparticles of greater or smaller size in said range of 15-500 nm in diameter. 5 . A method of synthesizing anisotropic gold nanoparticles, the method comprising: providing aurate ions, a ligand comprising thioctic acid, ascorbic acid, and hydroxide and allowing them to react in an aqueous phase, thereby obtaining anisotropic gold nanoparticles having diameters in a range of 15-500 nm, wherein the ligand is selected from the group consisting of thioctic acid-NH 2 (TA-NH 2 ), TA-nitrilotriacetic acid (TA-NTA), TA-polyethylene glycol-COOH (TA-PEG-COOH), and TA-polyethylene glycol-NH 2 (TA-PEG-NH 2 ).

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12485484B2 cover?
A new seedless synthesis of anisotropic nanoscale gold nanoflower (AuNF) particles uses bidentate thiolate ligands to protect the nanoparticle surface and a combination of reagents (for example, ligand, ascorbic acid, and hydroxide) to synthesis AuNF with controlled size and anisotropic properties. Compared to prior art gold nanospheres, AuNF produced approximately a 15-fold improvement in a dr…
Who is the assignee on this patent?
Us Gov Sec Navy
What technology area does this patent fall under?
Primary CPC classification B22F9/24. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Dec 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).